180 citations
,
June 2004 in “Journal of Pharmacology and Experimental Therapeutics” The study examined the role of progesterone receptors (PR) in the anticonvulsant effects of progesterone using PR knockout (PRKO) mice. It was discovered that the anticonvulsant potency of progesterone was not reduced in PRKO mice compared to wild-type controls, and in some seizure models, PRKO mice even showed increased potency. The reversal of anticonvulsant effects by finasteride suggested that these effects were due to the conversion of progesterone to the neurosteroid allopregnanolone, rather than the action of PRs. This indicated that PRs were not necessary for the antiseizure effects of progesterone, which were mainly mediated by allopregnanolone.
136 citations
,
January 2004 in “Neuroscience” The study investigated the role of testosterone in seizure susceptibility, focusing on its conversion to neurosteroids 3α-androstanediol (3α-Diol) and 17β-estradiol. It was found that testosterone decreased seizure thresholds and increased seizure severity in animal models, effects that were associated with elevated levels of these neurosteroids. The use of letrozole, an aromatase inhibitor, and finasteride, a 5α-reductase inhibitor, demonstrated that blocking the conversion of testosterone to 17β-estradiol and 3α-Diol, respectively, reduced its proconvulsant effects. The study concluded that these testosterone-derived neurosteroids significantly influenced neural excitability and seizure susceptibility.
269 citations
,
May 2002 in “Journal of Neuroscience” The study provided evidence that stress-induced neurosteroids derived from deoxycorticosterone (DOC) modulated GABA(A) receptor function and affected seizure susceptibility. During stress, DOC was metabolized into neurosteroids like THDOC, which had anticonvulsant properties. In rats, acute stress increased THDOC levels and raised seizure thresholds. Similarly, small doses of DOC increased THDOC and seizure thresholds, effects reversed by finasteride, a 5alpha-reductase inhibitor. DOC also protected mice against various seizures, with its effects reversed by finasteride and partially by indomethacin. DHDOC, another metabolite, also potentiated GABA-activated currents, suggesting its role in DOC's antiseizure activity. Thus, DOC mediated stress effects on seizures through conversion to neurosteroids affecting GABA(A) receptors.
115 citations
,
March 2001 in “Baillière's best practice and research in clinical endocrinology and metabolism/Baillière's best practice & research. Clinical endocrinology & metabolism” Key enzymes control androgen levels, affecting hormone activity and potential treatments.
48 citations
,
February 1999 in “PubMed” Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.
98 citations
,
April 1997 in “The Journal of Steroid Biochemistry and Molecular Biology” Finasteride effectively blocks rat enzymes, but with varying methods and strength.